Year-end Sale % OFF 
Abstract
This article provides a review of the important article by Buzaianu and Chen, appearing in this issue. While their recommended procedure is of interest, there are several practical considerations that would detract clinical trialists from applying these procedures. Six concerns are mentioned, including the definition of “correct selection” as finding a treatment truly superior to the control, continuation of the control therapy even after it was found to be inferior to an active treatment, and elimination of active treatments without definitive evidence it is inferior to other active treatments.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
